Systems Intervention to Promote Colorectal Cancer (CRC) Screening
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01299493|
Recruitment Status : Completed
First Posted : February 18, 2011
Last Update Posted : July 12, 2018
|Condition or disease||Intervention/treatment||Phase|
|Carcinoma||Other: Systems-level intervention to promote colon cancer screening||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||490 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Systems Intervention to Promote Colorectal Cancer Screening/ Program for the Elimination of Cancer Disparities|
|Actual Study Start Date :||June 19, 2012|
|Actual Primary Completion Date :||September 21, 2017|
|Actual Study Completion Date :||September 21, 2017|
Access to systems-level interventions to increase colorectal cancer screening.
Other: Systems-level intervention to promote colon cancer screening
Intervention practices will receive access to, and assistance in implementing, evidence-based strategies for increasing colorectal cancer screening rates.
No Intervention: Usual Care
Practices will receive access to intervention components after outcomes data collection is complete.
- Practice-level colon cancer screening rate [ Time Frame: 12-months post baseline ]Colorectal cancer screening will be assessed as the proportion of screening-eligible patients who are adherent to national screening guidelines for colorectal cancer.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01299493
|United States, Missouri|
|Washington University School of Medicine|
|Saint Louis, Missouri, United States, 63110|
|Principal Investigator:||Aimee S James, PhD, MPH||Washington University School of Medicine|